Delivery Order SPE2DB22D1106-SPE2DB25FEUW4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Promacta 50 mg tablets (30-count units) with a ceiling value of $8,026.53. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract vehicle with the DLA. The award was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract carries a ceiling value of $48,118.52 and operates under firm fixed pricing with an ultimate completion date of August 7, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $12,029.63, with an ultimate completion date of August 20, 2025. The contract is not set-aside and represents a competitively awarded procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $72,177.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is scheduled for completion by October 20, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,026.53 on August 27, 2025, for the supply of Promacta 50 mg tablets (30-count units). This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The delivery order is set to be completed by September...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This contract, valued at $17,672.24, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The ultimate completion date is set for September 30, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This award, valued at $16,053.06, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The contract is scheduled for ultimate completion by September 18, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract has a ceiling value of $8,026.53 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 15, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it...
- This delivery order, awarded July 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Promacta 25 mg tablets in quantities of 30 units. The contract carries a ceiling value of $4,418.06 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The award is unclassified as a set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $12,029.63 to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. PROMACTA is an immunosuppressant medication commonly used to treat thrombocytopenia in patients...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUW4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $12,029.63 and is scheduled for completion by July 16, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Promacta is a prescription medication used to treat immune thrombocytopenia and certain chronic hepatitis C conditions. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime pharmaceutical vendor contract serves as a comprehensive global medical supply vehicle enabling the contractor to deliver a broad range of pharmaceuticals, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated extensive capability in federal procurement through multiple competitively awarded contracts with DLA supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 6/24/25 |